| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.01 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.32 | 0.02 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.35 | 0.02 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.4 | 0.02 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.33 | 0.03 |